Clinical trial Recruiting at 1 site Observational Ages 40 to 64 Women only

AGEWISE: Exploring how the gut microbiome and hormones change as women age

Official title: AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing

Run by Gulbenkian Institute for Molecular Medicine · NCT07614542 · Data updated 2026-11-12

This study will look at how the gut microbiome relates to hormonal changes during menopause in healthy women aged 40–64 in Portugal to see if biomarkers can help predict health risks.

More Gut Microbiome trials

Quick facts

Study typeObservational
Ages40 Years to 64 Years
SexWomen only
Enrollment300 (estimated)
SponsorGulbenkian Institute for Molecular Medicine
Academic / other
Locations1 site (Lisbon)
StatusRecruiting
StartedJune 2, 2025
Main results expectedDecember 2026
Study endsDecember 2036
Registry record updatedMay 29, 2026
Trial IDNCT07614542 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy women aged 40–64 who reside in mainland Portugal or the islands and are willing to provide stool and blood samples and complete three questionnaires.

Probably not a fit

Participants without menopause-related changes or lacking identifiable biomarkers may not receive direct benefits beyond contributing to research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

AGEWISE is an observational study in healthy women aged 40–64 living in Portugal. Researchers will collect stool and blood samples and have participants complete questionnaires about health, lifestyle, diet, and menopausal symptoms. The goal is to link gut microbiome data with hormone levels and inflammation markers to understand menopause-related ageing and identify potential biomarkers for personalized risk assessment. Findings may inform prevention strategies for age-related health issues in women. No intervention is involved; the study observes natural changes across the menopausal transition.

Why it matters

Potential benefit: If successful, the study could identify microbiome and blood biomarkers that help tailor prevention strategies for menopause-related health risks.

How similar studies have gone: Prior studies have shown relationships between the gut microbiome, hormones, and inflammation in ageing, supporting the plausibility of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female sex
* Aged 40 to 64 years
* Resident in mainland Portugal or the islands
* Able and willing to provide written informed consent
* Willing to provide stool and blood samples and complete three questionnaires

Exclusion Criteria:

* Age below 40 years or 65 years and older
* Inability to give informed consent
* Refusal to provide stool or blood samples or complete questionnaires
* Pregnancy
* Diagnosed gastrointestinal disorders (including inflammatory bowel disease, Crohn's disease, ulcerative colitis, irritable bowel syndrome, chronic diarrhoea of unknown cause, or recurrent Clostridioides difficile infection)
* Active oncological disease

Where it's running

  • Gulbenkian Institute for Molecular Medicine, Lisbon
    Lisbon, Portugal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.